Abstract
MDMX and MDM2 are two nonredundant essential regulators of p53 tumor suppressor activity. MDM2 controls p53 expression levels, whereas MDMX is predominantly a negative regulator of p53 trans-activity. The feedback loops between MDM2 and p53 are well studied and involve both negative and positive regulation on transcriptional, translational and post-translational levels but little is known on the regulatory pathways between p53 and MDMX. Here we show that overexpression of p53 suppresses mdmx mRNA translation in vitro and in cell-based assays. The core domain of p53 binds the 5′ untranslated region (UTR) of the mdmx mRNA in a zinc-dependent manner that together with a trans-suppression domain located in p53 N-terminus controls MDMX synthesis. This interaction can be visualized in the nuclear and cytoplasmic compartment. Fusion of the mdmx 5′UTR to the ovalbumin open reading frame leads to suppression of ovalbumin synthesis. Interestingly, the transcription inactive p53 mutant R273H has a different RNA-binding profile compared with the wild-type p53 and differentiates the synthesis of MDMX isoforms. This study describes p53 as a trans-suppressor of the mdmx mRNA and adds a further level to the intricate feedback system that exist between p53 and its key regulatory factors and emphasizes the important role of mRNA translation control in regulating protein expression in the p53 pathway.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
de Oca Luna RM, Wagner DS, Lozano G . Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995; 378: 203–206.
Jones SN, Roe AE, Donehower LA, Bradley A . Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 1995; 378: 206–208.
Parant J, Chavez-Reyes A, Little NA, Yan W, Reinke V, Jochemsen AG et al. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet 2001; 29: 92–95.
Wade M, Wong ET, Tang M, Stommel JM, Wahl GM . Hdmx modulates the outcome of p53 activation in human tumor cells. J Biol Chem 2006; 281: 33036–33044.
Gu J, Kawai H, Nie L, Kitao H, Wiederschain D, Jochemsen AG et al. Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. J Biol Chem 2002; 277: 19251–19254.
Gajjar M, Candeias MM, Malbert-Colas L, Mazars A, Fujita J, Olivares-Illana V et al. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell 2012; 21: 25–35.
Malbert-Colas L, Ponnuswamy A, Olivares-Illana V, Tournillon AS, Naski N, Fahraeus R . HDMX folds the nascent p53 mRNA following activation by the ATM kinase. Mol Cell 2014; 54: 500–511.
Naski N, Gajjar M, Bourougaa K, Malbert-Colas L, Fahraeus R, Candeias MM . The p53 mRNA-Mdm2 interaction. Cell Cycle 2009; 8: 31–34.
Pant V, Xiong S, Jackson JG, Post SM, Abbas HA, Quintas-Cardama A et al. The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity. Genes Dev 2013; 27: 1857–1867.
Perry ME, Mendrysa SM, Saucedo LJ, Tannous P, Holubar M . p76(MDM2) inhibits the ability of p90(MDM2) to destabilize p53. J Biol Chem 2000; 275: 5733–5738.
Saucedo LJ, Myers CD, Perry ME . Multiple murine double minute gene 2 MDM2) proteins are induced by ultraviolet light. J Biol Chem 1999; 274: 8161–8168.
Tournillon AS, Lopez I, Malbert-Colas L, Naski N, Olivares-Illana V, Fahraeus R . The alternative translated MDMX(p60) isoform regulates MDM2 activity. Cell Cycle 2015; 14: 449–458.
Phillips A, Teunisse A, Lam S, Lodder K, Darley M, Emaduddin M et al. HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity. J Biol Chem 2010; 285: 29111–29127.
Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B . Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358: 80–83.
Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S et al. MDM4 is a key therapeutic target in cutaneous melanoma. Nat Med 2012; 18: 1239–1247.
Oren M, Rotter V . Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol 2010; 2: a001107.
Riley KJ, Maher LJ 3rd . p53 RNA interactions: new clues in an old mystery. RNA 2007; 13: 1825–1833.
Galy B, Creancier L, Prado-Lourenco L, Prats AC, Prats H . p53 directs conformational change and translation initiation blockade of human fibroblast growth factor 2 mRNA. Oncogene 2001; 20: 4613–4620.
Galy B, Creancier L, Zanibellato C, Prats AC, Prats H . Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism. Oncogene 2001; 20: 1669–1677.
Miller SJ, Suthiphongchai T, Zambetti GP, Ewen ME . p53 binds selectively to the 5' untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor beta- and p53-mediated translational inhibition of cdk4. Mol Cell Biol 2000; 20: 8420–8431.
Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, Deppert W . Negative feedback regulation of wild-type p53 biosynthesis. EMBO J 1995; 14: 4442–4449.
Mlynarczyk C, Fahraeus R . Endoplasmic reticulum stress sensitizes cells to DNA damage-induced apoptosis through p53-dependent suppression of p21(CDKN1A). Nat Commun 2014; 5: 5067.
Lopez I, Tournillon AS, Nylander K, Fahraeus R . p53-mediated control of gene expression via mRNA translation during endoplasmic reticulum stress. Cell Cycle 2015; 14: 3373–3378.
Cassiday LA, Maher LJ 3rd . Having it both ways: transcription factors that bind DNA and RNA. Nucleic Acids Res 2002; 30: 4118–4126.
Hudson WH, Ortlund EA . The structure, function and evolution of proteins that bind DNA and RNA. Nat Rev Mol Cell Biol 2014; 15: 749–760.
Suswam EA, Li YY, Mahtani H, King PH . Novel DNA-binding properties of the RNA-binding protein TIAR. Nucleic Acids Res 2005; 33: 4507–4518.
Danovi D, Meulmeester E, Pasini D, Migliorini D, Capra M, Frenk R et al. Amplification of Mdmx or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol Cell Biol 2004; 24: 5835–5843.
Mandke P, Wyatt N, Fraser J, Bates B, Berberich SJ, Markey MP . MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame. PLoS One 2012; 7: e42034.
Pavletich NP, Chambers KA, Pabo CO . The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 1993; 7: 2556–2564.
Kitayner M, Rozenberg H, Kessler N, Rabinovich D, Shaulov L, Haran TE et al. Structural basis of DNA recognition by p53 tetramers. Mol Cell 2006; 22: 741–753.
Grover R, Candeias MM, Fahraeus R, Das S . p53 and little brother p53/47: linking IRES activities with protein functions. Oncogene 2009; 28: 2766–2772.
Scrable H, Sasaki T, Maier B . DeltaNp53 or p44: priming the p53 pump. Int J Biochem Cell Biol 2005; 37: 913–919.
Yin Y, Stephen CW, Luciani MG, Fahraeus R . p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat Cell Biol 2002; 4: 462–467.
Kaustov L, Yi GS, Ayed A, Bochkareva E, Bochkarev A, Arrowsmith CH . p53 transcriptional activation domain: a molecular chameleon? Cell Cycle 2006; 5: 489–494.
Vise PD, Baral B, Latos AJ, Daughdrill GW . NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain. Nucleic Acids Res 2005; 33: 2061–2077.
Lunde BM, Moore C, Varani G . RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol 2007; 8: 479–490.
Riley KJ, Cassiday LA, Kumar A, Maher LJ 3rd . Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system. RNA 2006; 12: 620–630.
Acknowledgements
This work was supported by la Ligue Contre le Cancer and Inserm. A-ST is supported by PACRI. IL is supported by AXA Research Fund and Fondation pour la Recherche Médicale (FDT20150532276). BV was supported by GACR 16-07321S and BV and RF were supported by MEYS-NPS I-L01413 and MH CZ-DRO (MMCI, 00209805). We thank the IUH platform for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Tournillon, AS., López, I., Malbert-Colas, L. et al. p53 binds the mdmx mRNA and controls its translation. Oncogene 36, 723–730 (2017). https://doi.org/10.1038/onc.2016.236
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2016.236
This article is cited by
-
The p53 endoplasmic reticulum stress-response pathway evolved in humans but not in mice via PERK-regulated p53 mRNA structures
Cell Death & Differentiation (2023)
-
Biological roles of the RNA m6A modification and its implications in cancer
Experimental & Molecular Medicine (2022)
-
c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis
Nature Communications (2020)
-
The Sox2 transcription factor binds RNA
Nature Communications (2020)
-
Shaping the regulation of the p53 mRNA tumour suppressor: the co-evolution of genetic signatures
BMC Cancer (2019)